Table 2.
Variation in place of death and diagnostic sub-type by time from diagnosis to death
| |
Time from diagnosis to death |
|||||
|---|---|---|---|---|---|---|
|
Total |
0-1 month |
1-3 months |
3-6 months |
6 months-1 year |
1 year + |
|
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
|
Total deaths |
4829 (100) |
676 (100) |
623 (100) |
538 (100) |
767 (100) |
2225 (100) |
|
Place of death (total deaths) | ||||||
| Hospital |
3183 (65.9) |
593 (87.7) |
446 (71.6) |
332 (61.7) |
494 (64.4) |
1318 (59.2) |
| Home |
753 (15.6) |
42 (6.2) |
76 (12.2) |
90 (16.7) |
133 (17.3) |
412 (18.5) |
| Nursing home |
532 (11.0) |
23 (3.4) |
61 (9.8) |
72 (13.4) |
74 (9.6) |
302 (13.6) |
| Hospice |
361 (7.5) |
18 (2.7) |
40 (6.4) |
44 (8.2) |
66 (8.6) |
193 (8.7) |
|
Disease sub-type (hospital deaths)
1
| ||||||
| Myeloma |
572 (18.0) |
77 (13.0) |
85 (19.1) |
40 (12.1) |
98 (19.8) |
272 (20.6) |
| Diffuse large B-cell lymphoma |
535 (16.8) |
182 (30.7) |
98 (22.0) |
65 (19.6) |
79 (16.0) |
111 (8.4) |
| Myelodysplastic syndrome |
422 (13.2) |
27 (4.5) |
55 (12.3) |
68 (20.5) |
85 (17.2) |
187 (14.2) |
| Acute myeloid leukaemia |
413 (13.0) |
151 (25.5) |
82 (18.4) |
51 (15.3) |
48 (9.7) |
81 (6.1) |
| Chronic lymphocytic leukaemia |
276 (8.7) |
29 (4.9) |
14 (3.1) |
19 (5.7) |
35 (7.1) |
179 (13.6) |
| Myeloproliferative neoplasms |
161 (5.1) |
15 (2.5) |
8 (1.8) |
10 (3.0) |
18 (3.6) |
110 (8.3) |
| Hodgkin lymphoma |
94 (2.9) |
16 (2.7) |
20 (4.5) |
14 (4.2) |
14 (2.8) |
30 (2.3) |
| Follicular lymphoma |
91 (2.8) |
7 (1.2) |
7 (1.6) |
2 (0.6) |
16 (3.2) |
59 (4.5) |
| Acute lymphoblastic leukaemia |
53 (1.7) |
8 (1.3) |
10 (2.2) |
3 (0.9) |
14 (2.8) |
18 (1.4) |
| Others | 566 (17.8) | 81 (13.7) | 67 (15.0) | 60 (18.1) | 87 (17.6) | 271 (20.6) |
1Ordered by absolute number of hospital deaths.